130. Environ Health Perspect. 2018 Apr 23;126(4):047011. doi: 10.1289/EHP1837.Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study).Garcia-Saenz A(1)(2)(3), Sánchez de Miguel A(4)(5)(6)(7), Espinosa A(1)(2)(3)(8),Valentin A(1)(3)(8), Aragonés N(2)(9), Llorca J(2)(10), Amiano P(2)(11), MartínSánchez V(2)(12), Guevara M(2)(13), Capelo R(14), Tardón A(2)(15), Peiró-PerezR(2)(16), Jiménez-Moleón JJ(2)(17)(18), Roca-Barceló A(19), Pérez-Gómez B(2)(9), Dierssen-Sotos T(2)(10), Fernández-Villa T(2)(12), Moreno-Iribas C(13)(20),Moreno V(2)(21)(22), García-Pérez J(2)(9), Castaño-Vinyals G(1)(2)(3)(8), Pollán M(2)(9), Aubé M(6), Kogevinas M(1)(2)(3)(8).Author information: (1)ISGlobal (Barcelona Institute for Global Health), Barcelona, Spain(2)CIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y SaludPública (CIBERESP), Madrid, Spain(3)Universitat Pompeu Fabra (UPF), Barcelona, Spain(4)Instituto de Astrofísica de Andalucía (IAA)–Consejo Superior deInvestigaciones Científicas (CSIC), Granada, Spain(5)Departamento de Astrofísica y CC. de la Atmósfera, Universidad Complutense de Madrid, Madrid, Spain(6)Département de physique, Cégep de Sherbrooke, Sherbrooke, Canada(7)Environment and Sustainability Institute, University Exeter, Penryn, UK(8)IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain(9)Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain(10)Instituto de Investigación Marqués de Valdecilla (IDIVAL), Universidad deCantabria, Santander, Spain(11)Public Health Division of Gipuzkoa, Health Department of Basque Region, SanSebastian, Spain(12)Research Group on Gene–Environment Interactions and Health, University ofLeón, León, Spain(13)Instituto de Investigación Sanitaria de Navarra (IdiSNA), Instituto de Salud Pública de Navarra, Pamplona, Spain(14)Centro de Investigación en Salud y Medio Ambiente (CYSMA), Universidad deHuelva, Huelva, Spain(15)University Institute of Oncology (IUOPA), University of Oviedo, Oviedo, Spain(16)Centro de Salud Pública de Dénia, Consellería de Sanidad Universal y SaludPública, Generalitat Valenciana, Fundación para el Fomento de la InvestigaciónSanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain(17)Department of Preventive Medicine and Public Health, University of Granada,Granada, Spain(18)Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), ComplejoHospitales Universitarios de Granada/Universidad de Granada, Granada, Spain(19)Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan,Department of Health, Autonomous Government of Catalonia, Catalan Institute ofOncology, Girona, Spain(20)Red de Investigación en Servicios de Salud en Enfermedades Crónicas(REDISSEC), Madrid, Spain(21)Bellvitge Biomedical Research Institute ( IDIBELL), Catalan Institute ofOncology, L’Hospitalet de Llobregat, Spain(22)Department of Clinical Sciences, Faculty of Medicine, University ofBarcelona, L’Hospitalet del Llobregat, SpainBACKGROUND: Night shift work, exposure to light at night (ALAN) and circadiandisruption may increase the risk of hormone-dependent cancers.OBJECTIVES: We evaluated the association of exposure to ALAN during sleeping timewith breast and prostate cancer in a population based multicase-control study(MCC-Spain), among subjects who had never worked at night. We evaluatedchronotype, a characteristic that may relate to adaptation to light at night.METHODS: We enrolled 1,219 breast cancer cases, 1,385 female controls, 623prostate cancer cases, and 879 male controls from 11 Spanish regions in2008-2013. Indoor ALAN information was obtained through questionnaires. OutdoorALAN was analyzed using images from the International Space Station (ISS)available for Barcelona and Madrid for 2012-2013, including data of remotelysensed upward light intensity and blue light spectrum information for eachgeocoded longest residence of each MCC-Spain subject.RESULTS: Among Barcelona and Madrid participants with information on both indoor and outdoor ALAN, exposure to outdoor ALAN in the blue light spectrum wasassociated with breast cancer [adjusted odds ratio (OR) for highest vs. lowesttertile, OR=1.47; 95% CI: 1.00, 2.17] and prostate cancer (OR=2.05; 95% CI: 1.38,3.03). In contrast, those exposed to the highest versus lowest intensity ofoutdoor ALAN were more likely to be controls than cases, particularly forprostate cancer. Compared with those who reported sleeping in total darkness, menwho slept in "quite illuminated" bedrooms had a higher risk of prostate cancer(OR=2.79; 95% CI: 1.55, 5.04), whereas women had a slightly lower risk of breast cancer (OR=0.77; 95% CI: 0.39, 1.51).CONCLUSION: Both prostate and breast cancer were associated with high estimatedexposure to outdoor ALAN in the blue-enriched light spectrum.https://doi.org/10.1289/EHP1837.DOI: 10.1289/EHP1837 PMCID: PMC6071739PMID: 29687979 